Reishi and Blood Sugar / Diabetes
Explore mushroom research and guides on reishi and blood sugar / diabetes.
How Ganoderma lucidum Targets Insulin Resistance
Ganoderma lucidum targets insulin resistance through PTP1B inhibition and AMPK activation, two distinct mechanisms shown in animal research to improve cellular glucose uptake.
Reishi Alpha-Glucosidase Inhibition: Ganoderol B Explained
A specific triterpene in reishi's fruiting body, Ganoderol B, inhibits alpha-glucosidase more potently than acarbose in vitro. Here's what the research shows.
Reishi and Blood Sugar: What the Research Shows
Reishi has four blood-sugar pathways in the lab. Human trials have been mixed. Here's the Cochrane evidence and 2025 meta-analysis findings.
Reishi for Type 2 Diabetes: Clinical Evidence
Reishi showed opposing HbA1c results in clinical trials: one positive, the rest null. Here is why they differed and what the 2025 GRADE meta-analysis found.
Reishi Polysaccharides and Glucose Metabolism
Reishi polysaccharides act on glucose metabolism through three targets: hepatic glucose output, beta-cell protection, and peripheral glucose uptake via GLUT4 and AMPK.